Alagille Syndrome Clinical Trials in Brussels
2 recruitingBrussels, Belgium
Showing 1–2 of 2 trials
Recruiting
Phase 3
Long-term Safety and Efficacy of Odevixibat in Patients With Alagille Syndrome
Alagille Syndrome
Albireo, an Ipsen Company70 enrolled39 locationsNCT05035030
Recruiting
Phase 4
Long-Term Low-Intervention SafEty and Clinical Outcomes Clinical Study of LivmArli® in Patients With Alagille Syndrome in the European Union (LEAP-EU)
Alagille Syndrome
Mirum Pharmaceuticals, Inc.100 enrolled13 locationsNCT07290257